Inhibition of NF-KB-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAl-1
Open Access
- 11 October 1995
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 23 (19) , 3887-3893
- https://doi.org/10.1093/nar/23.19.3887
Abstract
The essential role of uroklnase-type plasminogen activator (uPA) in tumor invasion and metastasis stresses the necessity of a fine-tuned cellular control over its expression. It has been shown that changes in uPA directly correlate with changes in cell invasive ness. We examined the role of Rel-related proteins in uPA synthesis by human ovarian cancer cells by inhibiting their expression using the antisense (AS) oligodeoxynucleotide (ODN) technology. Exposure of OV-MZ-6 cells to 10μM phosphorothioate (PS)-dervatized AS-ODN directed to Rel A led to a maximal 50% decrease of uPA antigen in cell lysates and a 70% reduction in cell culture supematants accompanied by a significant transient decline in uPA mRNA levels. Antisense-PS-ODN directed to NF- k B1 (p50) or c-rel had no effect on uPA protein expression. AS-PS-ODN directed to Rel A also affected the proteotytic capacity of OV-MZ-6 cells reflected by an -70% decrease in the tibrinolytic capacity of the cells within 24 h compared to untreated controls. AS-PS-ODN directed to 1 k Bα expression increased uPA in cell culture supematants up to 50%. uPA receptor (uPAR) production and synthesis of plasminogen activator inhibitor type-1 (PM-1) were not altered by either AS-PS-ODN applied. Western blot and gel retardation analyses revealed constitutive expression of Relrelated proteins in nuclear protein extracts of OV-MZ-6 cells. Thus these proteins seem to be implicated in uPA regulation and may thereby contribute to tumor spread and metastasis.Keywords
This publication has 32 references indexed in Scilit:
- Gene inhibition using antisense oligodeoxynucleotidesNature, 1994
- Recombinant soluble urokinase receptor as a scavenger for urokinase‐type plasminogen activator (uPA)FEBS Letters, 1994
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasivenessBioEssays, 1993
- Ablation of Transplanted HTLV-I Tax-Transformed Tumors in Mice by Antisense Inhibition of NF-κBScience, 1992
- Functional analysis of the human vascular cell adhesion molecule 1 promoter.The Journal of Experimental Medicine, 1992
- Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell linesInternational Journal of Cancer, 1992
- Growth stimulation of human epidermal cells by urokinase is restricted to the intact active enzymeEuropean Journal of Biochemistry, 1989
- cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.Journal of Clinical Investigation, 1986
- NUCLEOSIDE PHOSPHOROTHIOATESAnnual Review of Biochemistry, 1985